HSA — authorised 29 September 1952
- Marketing authorisation holder: SANDOZ
- Status: likely_approved
HSA authorised Isoniazid on 29 September 1952
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 29 September 1952.
SANDOZ holds the Singaporean marketing authorisation.